Drug intelligence / Profile preview

Amitex PSE

Development stage
Discontinued
Lead developer
Allergan
Modality
Small Molecules
Administration
Oral
01

Overview

Amitex PSE is a combination pharmaceutical product containing the expectorant guaifenesin and the nasal decongestant pseudoephedrine. Formulated as an extended-release tablet, it is indicated for the temporary relief of cough and nasal congestion associated with the common cold, hay fever, or other upper respiratory allergies. Guaifenesin functions as an expectorant by thinning and loosening bronchial secretions, thereby increasing the efficiency of the cough reflex to remove accumulated mucus. Pseudoephedrine is a sympathomimetic amine that acts primarily as an agonist at alpha-adrenergic receptors in the respiratory mucosa, leading to vasoconstriction, reduced tissue hyperemia, and decreased nasal congestion. The product was manufactured by Actavis Totowa but was subject to a voluntary recall in 2008 due to manufacturing practice concerns.

Brand names
Amitex PSE
Other names
guaifenesin + pseudoephedrine
02

Targets

ADRA1A (α1A)ADRB1 (β1)

Beyond the preview

Go deeper on Amitex PSE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amitex PSE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call